185 related articles for article (PubMed ID: 36178067)
1. BACH1 promotes clear cell renal cell carcinoma progression by upregulating oxidative stress-related tumorigenicity.
Takemoto K; Kobatake K; Miura K; Fukushima T; Babasaki T; Miyamoto S; Sekino Y; Kitano H; Goto K; Ikeda K; Hieda K; Hayashi T; Hinata N; Kaminuma O
Cancer Sci; 2023 Feb; 114(2):436-448. PubMed ID: 36178067
[TBL] [Abstract][Full Text] [Related]
2. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
[TBL] [Abstract][Full Text] [Related]
3. microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells.
Li S; Chen T; Zhong Z; Wang Y; Li Y; Zhao X
Mol Med Rep; 2012 Apr; 5(4):949-54. PubMed ID: 22307849
[TBL] [Abstract][Full Text] [Related]
4. BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition.
Han W; Zhang Y; Niu C; Guo J; Li J; Wei X; Jia M; Zhi X; Yao L; Meng D
Cancer Lett; 2019 Mar; 445():45-56. PubMed ID: 30654010
[TBL] [Abstract][Full Text] [Related]
5. BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial-Mesenchymal Transition.
Sato M; Matsumoto M; Saiki Y; Alam M; Nishizawa H; Rokugo M; Brydun A; Yamada S; Kaneko MK; Funayama R; Ito M; Kato Y; Nakayama K; Unno M; Igarashi K
Cancer Res; 2020 Mar; 80(6):1279-1292. PubMed ID: 31919242
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor BACH1 at the crossroads of cancer biology: From epithelial-mesenchymal transition to ferroptosis.
Igarashi K; Nishizawa H; Saiki Y; Matsumoto M
J Biol Chem; 2021 Sep; 297(3):101032. PubMed ID: 34339740
[TBL] [Abstract][Full Text] [Related]
8. BACH1, the master regulator gene: A novel candidate target for cancer therapy.
Davudian S; Mansoori B; Shajari N; Mohammadi A; Baradaran B
Gene; 2016 Aug; 588(1):30-7. PubMed ID: 27108804
[TBL] [Abstract][Full Text] [Related]
9. BACH1 promotes the progression of human colorectal cancer through BACH1/CXCR4 pathway.
Zhu GD; Liu F; OuYang S; Zhou R; Jiang FN; Zhang B; Liao WJ
Biochem Biophys Res Commun; 2018 May; 499(2):120-127. PubMed ID: 29481800
[TBL] [Abstract][Full Text] [Related]
10. BACH1 promotes lung adenocarcinoma cell metastasis through transcriptional activation of ITGA2.
Chen Y; Jin L; Ma Y; Liu Y; Zhu Q; Huang Y; Feng W
Cancer Sci; 2023 Sep; 114(9):3568-3582. PubMed ID: 37311571
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of BACH1 mediated by IGF2 facilitates hepatocellular carcinoma growth and metastasis via IGF1R and PTK2.
Xie M; Sun M; Ji X; Li D; Chen X; Zhang B; Huang W; Zhang T; Wang Y; Tian D; Xia L
Theranostics; 2022; 12(3):1097-1116. PubMed ID: 35154476
[No Abstract] [Full Text] [Related]
12. Downregulation of Bach1 protects osteoblasts against hydrogen peroxide-induced oxidative damage in vitro by enhancing the activation of Nrf2/ARE signaling.
Tian X; Cong F; Guo H; Fan J; Chao G; Song T
Chem Biol Interact; 2019 Aug; 309():108706. PubMed ID: 31194955
[TBL] [Abstract][Full Text] [Related]
13. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
Lin H; Zeng W; Lei Y; Chen D; Nie Z
Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
[TBL] [Abstract][Full Text] [Related]
14. Kindlin‑2 promotes clear cell renal cell carcinoma progression through the Wnt signaling pathway.
Li M; Pei X; Wang G; Zhan J; Du J; Jiang H; Tang Y; Zhang H; He H
Oncol Rep; 2017 Sep; 38(3):1551-1560. PubMed ID: 28677779
[TBL] [Abstract][Full Text] [Related]
15. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
17. Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression.
Shajari N; Davudian S; Kazemi T; Mansoori B; Salehi S; Khaze Shahgoli V; Shanehbandi D; Mohammadi A; Duijf PHG; Baradaran B
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1495-1504. PubMed ID: 28889753
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma.
Zhang M; Lu W; Huang Y; Shi J; Wu X; Zhang X; Jiang R; Cai Z; Wu S
J Mol Histol; 2016 Aug; 47(4):421-8. PubMed ID: 27323757
[TBL] [Abstract][Full Text] [Related]
19. A Novel Therapeutic Target, BACH1, Regulates Cancer Metabolism.
Padilla J; Lee J
Cells; 2021 Mar; 10(3):. PubMed ID: 33809182
[TBL] [Abstract][Full Text] [Related]
20. The dual role and mutual dependence of heme/HO-1/Bach1 axis in the carcinogenic and anti-carcinogenic intersection.
Xu J; Zhu K; Wang Y; Chen J
J Cancer Res Clin Oncol; 2023 Jan; 149(1):483-501. PubMed ID: 36310300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
